Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Sinclair, Inc. announced that IATSE Local 600 has voluntarily disclaimed interest and will no longer represent the news photojournalists at KOMO/KUNS in Seattle following an employee-initiated decertification vote. Sinclair emphasizes its commitment to maintaining a direct and positive relationship with its employees as it continues its operations …
Fortinet combines a durable, ASIC-accelerated security platform with strong cash generation and accelerating revenue, but it trades at a premium multiple and elevated EV/sales that limit upside. The trade: a measured mid-term long with defined risk controls while monitoring growth and margin trajectory.
MercadoLibre is trading well below its 52-week high after a correction that amplified concerns tied to Brazil. The company reported blowout revenue growth and strong fintech traction; balance sheet and cash flow strength support a tactical long. Entry at $1947.26, stop at $1800, target $2500 over a long term (180 trading days) horizon.
Entera Bio Ltd., a clinical-stage biotechnology company focused on developing oral peptide and protein replacement therapies, announced that CEO Miranda Toledano will participate in several upcoming healthcare investor conferences this fall. The company is advancing multiple oral peptide programs, including EB613 for osteoporosis, EB612 for hypopar…
Sui Basecamp 2026 will convene founders, builders, investors, and technologists at Marina Bay Sands in Singapore on October 7-8, colocated with TOKEN2049. The agenda focuses on the emerging agentic economy - autonomous, machine-driven transactions - covering instant settlement, private transactions, stable digital dollars, and post-quantum security…
Our Bond, Inc. (NASDAQ: OBAI), a leader in AI-powered preventative personal security, announced a major presence at the Global Security Exchange (GSX) 2026 in Atlanta. The company will demonstrate its innovative platform that combines AI with trained personal security agents to proactively protect individuals. Bond will also highlight recent EY res…
Healthy Choice Wellness Corp. has received stockholder approval to merge with Host Digital Infrastructure LLC, a digital infrastructure platform specializing in AI and high-performance computing data centers. The merger, expected to close by mid-September, will result in Host Digital becoming a wholly owned subsidiary of HCWC and the combined entit…
Moomoo, a global investment and trading platform and subsidiary of Nasdaq-listed Futu Holdings, announced a multi-year partnership with the LPGA to present the Futu Ladies World Championship. The tournament will debut in Hong Kong in March 2027 with a $3.4 million purse, the highest for any LPGA event in Asia, aiming to elevate women's professional…
Eos Energy Enterprises announced the consolidation of its battery manufacturing operations to its Thorn Hill facility in Warrendale, PA, improving manufacturing efficiency and capacity. The move is expected to reduce conversion costs by 10-15%, with operational benefits starting in 2027. Approximately 250 employees will be offered relocation or rea…
Rocket Lab (RKLB) is priced for perfection on Neutron, but the business can still deliver a credible quarter driven by launches, backlog and defense contracts. The trade: go long near $67 with a $57 stop and a $95 target over the next 45 trading days, while watching Neutron schedule and margins closely.
MISTRAS Group, a leader in industrial asset integrity and testing solutions, is accelerating its AI strategy to transform its expertise, data, and digital capabilities into actionable insights. The company appointed Samer F. Sarrouh as Executive Director of Artificial Intelligence to lead this initiative, aiming to improve inspection intelligence, …
ACI Worldwide is a profitable, cash-generative payments software company trading at a reasonable multiple with a clear path to higher recurring revenue and margins. Recent M&A, product wins in open banking and a large addressable market for real-time payments support a long trade. Entry at $53.00, stop at $48.00, target $65.00 over a long-term (180…
SEALSQ Corp announced that its majority-owned subsidiary, Wecan Group, has partnered with Swiss digital-asset platform SwissBorg to list the WECAN token. This collaboration integrates Wecan's institutional-grade compliance infrastructure with SwissBorg's regulated platform, enhancing trust, transparency, and access in the digital asset economy. SEA…
Semtech Corporation (NASDAQ:SMTC) saw its shares jump in premarket trading after Northland moved the stock from Market Perform to Outperform and set a $182 price target. Northland pointed to the company's connectivity solutions gaining adoption in AI infrastructure and noted data center revenue now represents 30% of total sales, with expectations i…
Members of the HD Hyundai Heavy Industries union voted in a ballot held August 25-27 to authorize strike action, with 5,379 of 8,127 members supporting the move. The result, representing 66.19% of eligible union members, clears the legal threshold for a strike. A Central Dispute Countermeasures Committee meeting is scheduled for August 28 to decide…
T1 Energy Inc. announced that Mo i Rana local officials have rezoned part of its Giga Arctic campus to permit the development of a 50 MW data center, expected to be operational in 2027 with potential for expansion. The company is pursuing various strategies to monetize this brownfield facility as part of its value optimization initiative, leveragin…
JPMorgan opened coverage of Benefit Systems with an Overweight rating and assigned a December 2027 price target of 6,685 Polish zloty, indicating roughly 25% upside from current levels. The $4.8 billion market-cap business, known for its MultiSport card and owned fitness clubs, is judged to benefit from low market penetration, consolidation opportu…
Myriad Genetics, a molecular diagnostic and precision medicine company, announced that its management will present at the 21st Annual Wells Fargo Healthcare Conference on September 10, 2026. The presentation will discuss the company’s portfolio and advancements in molecular testing and precision medicine.
Royal Philips and Imricor Medical Systems have launched a new Interventional MR (iMR) lab solution combining Philips' 1.5T MRI platform and Imricor's MR-compatible cardiac intervention systems. This solution aims to enable MRI-guided cardiac interventions with improved tissue visualization, reducing reliance on X-ray fluoroscopy and radiation expos…
Moleculin Biotech's CEO Walter Klemp presented promising interim results from the pivotal Phase 2/3 MIRACLE trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML). The presentation emphasized the drug's differentiated clinical profile, ongoing enrollment, expanding commercial potential, and an upcoming interim analysis of 90 pat…
Ernexa Therapeutics, a Nasdaq-listed biotechnology company, participated in a virtual investor conference to present its transition towards a clinical-stage company with its lead cell therapy candidate ERNA-101 advancing toward IND submission and an upcoming Phase 1 clinical trial. The company emphasized its innovative off-the-shelf iMSC platform t…
GRI Bio, a biotechnology company listed on NASDAQ, announced its feature in the 'Why Now' on-demand video webcast, showcasing its work on developing therapies for inflammatory, fibrotic, and autoimmune diseases.
Akari Therapeutics presented at the Virtual Investor "Why Now" conference to showcase its novel antibody drug conjugates (ADCs) with PH1 RNA splicing modulator payloads targeting cancer. The company emphasizes the potential advantages of its lead candidate AKTX-101 and plans to initiate a First-In-Human trial by mid-2027, aiming to address limitati…
Outlook Therapeutics CEO Bob Jahr participated in the Virtual Investor "Why Now" on-demand conference highlighting the company's transition to a commercial-stage biopharmaceutical firm following the FDA approval of LYTENAVA, the only FDA-approved ophthalmic bevacizumab for wet AMD in the U.S. He emphasized the significant market opportunity, ongoin…
AIM ImmunoTech presented at the Virtual Investor 'Why Now' on-demand conference, focusing on their lead product Ampligen's advancement in the Phase 2 DURIPANC trial for metastatic pancreatic cancer. The trial has successfully completed enrollment ahead of schedule, with the final patient dosed. Topline results from the primary endpoint evaluation a…
